Why ERS Early Career Members should attend the International Congress 2019 in Madrid
- PMID: 31191724
- PMCID: PMC6544792
- DOI: 10.1183/20734735.0018-2019
Why ERS Early Career Members should attend the International Congress 2019 in Madrid
Abstract
The #ERSCongress is the largest respiratory conference worldwide. This article points out why @ERSTalk Early Career Members can especially benefit from attending this huge event and gives upcoming fellowship deadlines. http://ow.ly/3GQ530o8Ezh.
Conflict of interest statement
Conflict of interest: N. Ubags has nothing to disclose. Conflict of interest: M. Platé has nothing to disclose. Conflict of interest: I. Almendros has nothing to disclose. Conflict of interest: S. Bartel reports a grant and personal fees for advisory board membership from Bencard Allergie GmbH outside the submitted work.
Similar articles
-
Zooming in on the ERS fellowships and the International Congress.Breathe (Sheff). 2018 Jun;14(2):141-144. doi: 10.1183/20734735.001818. Breathe (Sheff). 2018. PMID: 29875833 Free PMC article.
-
Early Career Members at the ERS International Congress London 2016: Early Career Forum.Breathe (Sheff). 2016 Dec;12(4):364-368. doi: 10.1183/20734735.017216. Breathe (Sheff). 2016. PMID: 28210322 Free PMC article.
-
Early Career Members at the ERS International Congress 2017: highlights from the Assemblies.Breathe (Sheff). 2017 Dec;13(4):e121-e129. doi: 10.1183/20734735.017617. Breathe (Sheff). 2017. PMID: 29928461 Free PMC article.
-
ERS International Congress, Madrid, 2019: highlights from the Sleep and Clinical Physiology Assembly.ERJ Open Res. 2020 Jul 20;6(2):00373-2019. doi: 10.1183/23120541.00373-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32714963 Free PMC article. Review.
-
ERS International Congress, Madrid, 2019: highlights from the Epidemiology and Environment Assembly.ERJ Open Res. 2020 Feb 3;6(1):00320-2019. doi: 10.1183/23120541.00320-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32039257 Free PMC article. Review.
References
-
- Oude Blenke E, Evers MJW, Mastrobattista E, et al. . CRISPR–Cas9 gene editing: delivery aspects and therapeutic potential. J Control Release 2016; 244: 139–148. - PubMed
-
- Shen S, Sanchez ME, Blomenkamp K, et al. . Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice. Hum Gene Ther 2018; 29: 861–873. - PubMed
-
- Hart SL, Harrison PT. Genetic therapies for cystic fibrosis lung disease. Curr Opin Pharmacol 2017; 34: 119–124. - PubMed
LinkOut - more resources
Full Text Sources